Physician profile
Melissa Micari
NPI 1124478052
$651.16
in general payments reported to CMS, 2019-2025
8 companies · $51.91 in 2025
The $51.91 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $123 · 2023: $395 · 2024: $81.13 · 2025: $51.91.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $453 · Education: $74.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $452.90 |
| Education | $74.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $270.05 | 2023-2025 | |
| Janssen Biotech, INC. | $227.71 | 2022-2024 | Tremfya, Simponi Aria |
| Amgen INC. | $61.80 | 2023 | Enbrel, Otezla, Tavneos |
| Pacira Pharmaceuticals Incorporated | $26.13 | 2023 | Iovera, Zilretta |
| Ani Pharmaceuticals, INC. | $21.66 | 2023 | Purified Cortrophin Gel |
| Lilly USA, LLC | $15.52 | 2023 | Taltz |
| Alexion Pharmaceuticals, INC. | $14.91 | 2023 | Strensiq |
| Ucb, INC. | $13.38 | 2023 | Cimzia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Micari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.